يعرض 1 - 10 نتائج من 1,338 نتيجة بحث عن '"stereotactic radiosurgery"', وقت الاستعلام: 1.21s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Malignant tumours; Том 14, № 1 (2024); 83-91 ; Злокачественные опухоли; Том 14, № 1 (2024); 83-91 ; 2587-6813 ; 2224-5057

    وصف الملف: application/pdf

    العلاقة: https://www.malignanttumors.org/jour/article/view/1289/919Test; Яровой А.А., Голанов А.В., Ильялов С.Р. и соавт. Стереотаксическая радиохирургия «Гамма-нож» как альтернатива энуклеации у пациентов с увеальной меланомой (первые результаты). Офтальмохирургия 2014;2:74–80.; Яровой А.А., Демидов Л.В., Зарецкий А.Р., Яровая В.А., Назарова В.В., Чудакова Л.В. и др. Способ определения тактики ведения пациентов с увеальной меланомой: Патент № 2019136524. 2019; Singh A.D., Bergman L., Seregard S. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am 2005;18(1):75– 84. https://doi.org/10.1016/j.ohc.2004.07.002Test; Damato E.M., Damato B.E. Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2384 patients. Ophthalmology 2012;119(8):1582–9. https://doi.org/10.1016/j.ophtha.2012.01.048Test; Яровой А.А., Малюгин Э.Б., Яровая В.А. и соавт. Тонкоигольная аспирационная биопсия внутриглазных образований. Офтальмохирургия 2020;1:51–56. https://doi.org/10.25276/0235-4160-2020-1-51-56Test.; Margo C.E. The collaborative ocular melanoma study: an overview. Cancer Control 2004;11(5):304–309. https://doi.org/10.1177/107327480401100504Test; Яровой А.А. Органосохраняющее и функционально-сберегающее лечение меланомы хориоидеи на основе брахитерапии с рутением-106 и лазерной транспупиллярной термотерапии. Дис. . д-ра мед. наук. М., 2010.; Shah A.A., Bourne T.D., Murali R. BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Pathology 2013;45(7):651–6. https://doi.org/10.1097/PAT.0000000000000002Test; Damato B., Kacperek A., Errington D., Heimann H. Proton beam radiotherapy of uveal melanoma. Saudi J Ophthalmol 2013;27(3):151–157. https://doi.org/10.1016/j.sjopt.2013.06.014Test; Саакян С.В., Бородин Ю.И., Ширина Т.В. Оценка эффективности лечения и выживаемости больных увеальной меланомой после лечения медицинским узким протонным пучком. Радиология-практика 2012;6:49–53; Синявский О.А., Трояновский Р.Л., Иванов П.И. и соавт. Пятилетний опыт резекции увеальных меланом после стереотаксической радиохирургии с использованием гамма-ножа. Современные технологии в офтальмологии 2018;1:316–319.; Parker T., Rigney G., Kallos J., et al. Gamma knife radiosurgery for uveal melanomas and metastases: a systematic review and meta-analysis. Lancet Oncol 2020;21(11):1526–1536. https://doi.org/10.1016/S1470-2045Test(20)30459-9; Shields C.L., Say E.A. T., Hasanreisoglu M., et al. Personalized prognosis of uveal melanoma based on cytogenetic profile in 1059 patients over an 8-year period: the 2017 Harry S. Gradle Lecture. Ophthalmology 2017;124(10):1523– 1531. https://doi.org/10.1016/j.ophtha.2017.04.003Test; Cicinelli M.V., Nicola M.D., Gigliotti C.R., et al. Predictive factors of radio-induced complications in 194 eyes undergoing gamma knife radiosurgery for uveal melanoma. Acta Ophthalmol 2021;99(8):e1458-e1466. https://doi.org/10.1111/aos.14814Test; Яровая В.А. Прогностическая тонкоигольная аспирационная биопсия увеальной меланомы. Дис. . канд. ме. наук. М., 2020.; Kilic E., Naus N.C., van Gils W., et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci 2005;46(7):2253–7. https://doi.org/10.1167/iovs.04-1460Test; Singh N., Bergman L., Seregard S., Singh A.D. Uveal melanoma: epidemiologic aspects. Clinical Ophthalmic Oncology. Uveal Tumors 2014:75–88. https://doi.org/10.1007/978-3-642-54255-8_6Test; Carvajal R.D., Schwartz G.K., Tezel T., et al. Metastatic disease from uveal melanoma: treatment options and future prospects. Br J Ophthalmol 2017;101(1):38–44. https://doi.org/10.1136/bjophthalmol-2016-309034Test; https://www.malignanttumors.org/jour/article/view/1289Test

  2. 2
    دورية أكاديمية

    المؤلفون: Gloi, Aime M.

    المصدر: International Journal of Research in Medical Sciences; Vol. 12 No. 2 (2024): February 2024; 566-571 ; 2320-6012 ; 2320-6071

    وصف الملف: application/pdf

  3. 3
    دورية أكاديمية
  4. 4
  5. 5
    دورية أكاديمية
  6. 6
    دورية أكاديمية
  7. 7
    دورية أكاديمية

    المصدر: Revista Med; Vol. 31 No. 2 (2023); 71 - 78 ; Revista Med; Vol. 31 Núm. 2 (2023); 71 - 78 ; 1909-7700 ; 0121-5256

    وصف الملف: application/pdf

    العلاقة: https://revistas.unimilitar.edu.co/index.php/rmed/article/view/7041/5787Test; Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment. Asian Pac J Cancer Prev. 2017;18(1):3-9. https://journal.waocp.org/article_42593.htmlTest; Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002 Oct;4(4):278–99.; National Cancer Institute. Glioblastoma Multiforme Study.; Batchelor T, Shih HA. Management of glioblastoma in older adults. UpToDate. Published online August 15, 2023.; Rigamonti A, Simonetti G, Silvani A, et al. Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patients. Neurological Sciences. 2021;42(5):1879-1886. https://link.springer.com/article/10.1007/s10072-020-04725-7Test; Omuro A, Beal K, Gutin P, et al. Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma. Clinical Cancer Research. 2014;20(19):5023-5031. https://aacrjournals.org/clincancerres/article/20/19/5023/208813/Phase-II-Study-of-Bevacizumab-Temozolomide-andTest; Guan Y, Xiong J, Pan M, et al. Safety and efficacy of Hypofractionated stereotactic radiosurgery for high-grade Gliomas at first recurrence: a single-center experience. BMC Cancer. 2021;21(1):123. https://bmccancer.biomedcentral.com/articles/10.1186/s12885-021-07856-yTest; Strickland BA, Zada G. 5-ALA Enhanced Fluorescence−Guided Microscopic to Endoscopic Resection of Deep Frontal Subcortical Glioblastoma Multiforme. World Neurosurg. 2021;148:65. https://linkinghub.elsevier.com/retrieve/pii/S1878875021000127Test; Vogelbaum MA, Kroll D, Etame A, et al. A Prospective Validation Study of the First 3D Digital Exoscope for Visualization of 5-ALA–Induced Fluorescence in High-Grade Gliomas. World Neurosurg. 2021;149:e498-e503.https://www.sciencedirect.com/science/article/abs/pii/S1878875021001789?via%3DihubTest; Waqar M, Roncaroli F, Djoukhadar I, et al. Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG) - A phase I trial. Clin Transl Radiat Oncol. 2023;39:100585. https://linkinghub.elsevier.com/retrieve/pii/S1878875021001789Test; Omuro A, DeAngelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA. 2013;310(17):1842-1850.https://jamanetwork.com/journals/jama/article-abstract/1764056Test; Amelio D, Amichetti M. Radiation therapy for the treatment of recurrent glioblastoma: an overview. Cancers (Basel). 2012;4(1):257-280. https://www.mdpi.com/2072-6694/4/1/257Test; Lehrer EJ, Ruiz-Garcia H, Nehlsen AD, et al. Preoperative Stereotactic Radiosurgery for Glioblastoma. Biology (Basel). 2022;11(2):194. https://www.mdpi.com/2079-7737/11/2/194Test; Sulman EP, Ismaila N, Armstrong TS, et al. Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline. J Clin Oncol. 2017;35(3):361-369.https://www.mdpi.com/2079-7737/11/2/194Test; Chargari C, Magne N, Guy JB, et al. Optimize and refine therapeutic index in radiation therapy: Overview of a century. Cancer Treat Rev. 2016;45:58-67. https://linkinghub.elsevier.com/retrieve/pii/S0305737216000335Test; Waqar M, Trifiletti DM, McBain C, et al. Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature. Curr Oncol Rep. 2022;24(3):311-324. https://link.springer.com/article/10.1007/s11912-021-01157-0Test; Clarke J, Neil E, Terziev R, et al. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma. Int J Radiat Oncol Biol Phys. 2017;99(4):797-804.https://linkinghub.elsevier.com/retrieve/pii/S0360301617335496Test; Minniti G, Niyazi M, Alongi F, Navarria P, Belka C. Current status and recent advances in reirradiation of glioblastoma. Radiat Oncol. 2021;16(1):36. https://ro-journal.biomedcentral.com/articles/10.1186/s13014-021-01767-9Test; Mantica M, Drappatz J, Lieberman F, Hadjipanayis CG, Lunsford LD, Niranjan A. Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme. J Neurooncol. 2023;164(1):179-190. https://link.springer.com/article/10.1007/s11060-023-04398-0Test; Kulinich DP, Sheppard JP, Nguyen T, et al. Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review. Acta Neurochir (Wien). 2021;163(7):1921-1934.https://link.springer.com/article/10.1007/s00701-021-04794-3Test; https://revistas.unimilitar.edu.co/index.php/rmed/article/view/7041Test

  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية